CIK 0001768446 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Climb Bio, Inc.
Sign in to watch- Ticker
- CLYM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832273741
- Phone
- 1-866-857-2596
- Business address
- 20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
- Former names
- Eliem Therapeutics, Inc.
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 13,008,546 shares at $3.84 ($49,952,817)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 103,907 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Regulation FD disclosure · Other events
- 8-K Event Shareholder vote results · Other events
- 4 Open-market sale CHIEF ACCOUNTING OFFICER sold 1,245 shares at $7.21 ($8,982)
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change · Other events
- SC 13D/A Stake Beneficial Ownership Report
Page 9 of 17 · 326 filings